Effect of silk fibroin peptide derived from silkworm Bombyx mori on the anti-inflammatory effect of Tat-SOD in a mice edema model

BMB Reports

Volumn 44, Issue 12, 2011, Pages 787-792

  Kim, Dae Won ^a   Hwang, Hyun Sook ^a   Kim, Duk Soo ^b   Sheen, Seung Hoon ^c   Heo, Dong Hwa ^c   Hwang, Gyojun ^c   Kang, Suk Hyung ^c   Kweon, HaeYong ^d   Jo, You Young ^d   Kang, Seok Woo ^d   Lee, Kwang Gill ^d   Park, Kye Won ^e   Han, Kyu Hyung ^a   Park, Jinseu ^a   Eum, Won Sik ^a   Cho, Yong Jun ^c   Choi, Hyun Chul ^c   Choi, Soo Young ^a  

^a Hallym University   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Hallym University Medical Center   (South Korea)

^d National Institute of Animal Science   (South Korea)

^e Sungkyunkwan University   (South Korea)

Author keywords

Inflammation; Protein therapy; Silk fibroin; Tat superoxide dismutase; Tpa

Indexed keywords

12 O TETRADECANOYLPHORBOL 1,3 ACETATE; 12-O-TETRADECANOYLPHORBOL-1,3-ACETATE; DRUG DERIVATIVE; FIBROIN; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDE; PHORBOL 13 ACETATE 12 MYRISTATE; SUPEROXIDE DISMUTASE; TRANSACTIVATOR PROTEIN;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; EDEMA; GENETICS; HUMAN; INFLAMMATION; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; MOUSE; PATHOLOGY; SILKWORM; SKIN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BOMBYX; DISEASE MODELS, ANIMAL; EDEMA; FIBROINS; GENE PRODUCTS, TAT; HUMANS; INFLAMMATION; MALE; MICE; MICE, INBRED ICR; PEPTIDES; SKIN; SUPEROXIDE DISMUTASE; TETRADECANOYLPHORBOL ACETATE;

BOMBYX MORI; MUS;

EID: 84863255187     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2011.44.12.787     Document Type: Article

References (27)

1. Wu, J. N. (2005) An illustrated Chinese material medica, pp. 140-141, Oxford, New York, U.S.A.
2. Kim, J. Y., Choi, J. Y., Jeong, J. H., Jang, E. S., Kim, A. S., Kim, S. G., Kweon, H. Y., Jo, Y. Y. and Yeo, J. H. (2010) Low molecular weight silk fibroin increases alkaline phosphatase and type I collagen expression in MG63 cells. BMB Rep. 43, 52-56.
3. Lu, S., Wang, X., Lv, Q., Hu, X., Uppal, N., Omenetto, F. and Kaplan, D. L. (2009) Stabilization of enzymes in silk films. Biomacromolecules 10, 1032-1042.
4. Hyun, C. K., Kim, I. Y. and Frost, S. C. (2004) Soluble fibroin enhances insulin sensitivity and glucose metabolism in 3T3-L1 adipocytes. J. Nutr. 134, 3257-3263.
5. Igarashi, K., Yoshioka, K., Mizutani, K., Miyakoshi, M., Murakami, T. and Akizawa, T. (2006) Blood pressure-depressing activity of a peptide derived from silkworm fibroin in spontaneously hypertensive rats. Biosci. Biotechnol. Biochem. 70, 517-520.
6. Dietz, G. P. (2010) Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research. Curr. Pharm. Biotechol. 11, 167-174.
7. Wadia, J. S. and Dowdy, S. F. (2002) Protein transduction technology. Curr. Opin. Biotechnol. 13, 52-56.
8. Liochev, S. I. and Fridovich, I. (2010) Mechanism of the peroxidase activity of Cu, Zn superoxide dismutase. Free Radic. Biol. Med. 48, 1565-1569.
9. Ahn, E. H., Kim, D. W., Kang, H. W., Shin, M. J., Won, M. H., Kim, J., Kim, D. J., Kwon, O. S., Kang, T. C., Han, K. H., Park, J., Eum, W. S. and Choi, S. Y. (2010) Transduced PEP-1-ribosomal protein S3 (rpS3) ameliorates 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice. Toxicology 276, 192-197.
10. Choi, H. S., An, J. J., Kim, S. Y., Lee, S. H., Kim, D. W., Yoo, K. Y., Won, M. H., Kang, T. C., Kwon, H. J., Kang, J. H., Cho, S. W., Kwon, O. S., Park, J., Eum, W. S. and Choi, S. Y. (2006) PEP-1-SOD fusion protein efficiently protects against paraquat-induced dopaminergic neuron damage in a Parkinson disease mouse model. Free Radic. Biol. Med. 41, 1058-1068.
11. Kim, D. W., Lee, S. H., Jeong, M. S., Sohn, E. J., Kim, M. J., Jeong, H. J., An, J. J., Jang, S. H., Won, M. H., Hwang, I. K., Cho, S. W., Kang, T. C., Lee, K. S., Park, J., Yoo, K. Y., Eum, W. S. and Choi, S. Y. (2010) Transduced Tat-SAG fusion protein protects against oxidative stress and brain ischemic insult. Free Radic. Biol. Med. 48, 969-977.
12. Ahn, E. H., Kim, D. W., Kim, D. S., Woo, S. J., Kim, H. R., Kim, J., Lim, S. S., Kang, T. C., Kim, D. J., Suk, K.T., Park, J., Luo, Q., Eum, W. S., Hwang, H. S. and Choi, S. Y. (2011) Levosulpiride, (S)-(-)-5-aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl) methyl]-2-methoxybenzamide, enhances the transduction efficiency of PEP-1-ribosomal protein S3 in vitro and in vivo. BMB Rep. 44, 329-334.
13. Lee, S. H., Jeong, H. J., Kim, D. W., Sohn, E. J., Kim, M. J., Kim, D. S., Kang, T. C., Lim, S. S., Kang, I. J., Cho, S. W., Lee, K. S., Park, J., Eum, W. S. and Choi, S. Y. (2010) Enhancement of HIV-1 Tat fusion protein transduction efficiency by bog blueberry anthocyanins. BMB Rep. 43, 561-566.
14. Eum, W. S., Choung, I. S., Li, M. Z., Kang, J. H., Kim, D. W., Park, J., Kwon, H. I. and Choi, S. Y. (2004) HIV-1 Tat-mediated protein transduction of Cu, Zn-superoxide dismutase into pancreatic beta cells in vitro and in vivo. Free Radic. Biol. Med. 37, 339-349.
15. Floyd, R. A. (1990) Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 4, 2587-2597.
16. Stanley, P. L., Steiner, S., Havens, M. and Tramposch, K. M. (1991) Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate. Skin Pharmacology 4, 262-271.
17. Bickers, D. R. and Athar, M. (2006) Oxidative stress in the pathogenesis of skin disease. J. Invest. Dermatol. 126, 2565-2575.
18. Grilli, M. and Memo, M. (1999) Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal pathway. Cell Death Differ. 6, 22-27.
19. Baldwin, Jr, A. S. (2001) Series introduction: The transcription factor NF-κB and human disease. J. Clin. Invest. 107, 3-6.
20. Nathan, C. (2002) Points of control in inflammation. Nature 420, 846-852.
21. Mates, J. M. (2000) Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 83, 83-104.
22. Muzykantov, V. R. (2001) Targeting of superoxide dismutase and catalase to vascular endothelium. J. Control. Release 71, 1-21.
23. Wang, F., Arun, P., Friedman, J., Chen, Z. and Van Waes, C. (2009) Current and potential inflammation targeted therapies in head and neck cancer. Curr. Opin. Pharmacol. 9, 389-395.
24. Egbers, J. H., Cloosters, V., Noack, A., Schniewind, B., Thon, L., Klose, S., Kettler, B., von Forsner, C., Kneitz, C., Tepel, J., Adam, D., Wajant, H., Kalthoff, H. and Trauzold, A. (2008) Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. Cancer Res. 68, 1443-1450.
25. Van Waes, C. (2007) Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin. Cancer Res. 13, 1076-1082.
26. Aggarwal, S., Takada, Y., Singh, S., Myers, J. N. and Aggarwal, B. B. (2004) Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int. J. Cancer 111, 679-692.
27. Dhillon, N., Aggarwal, B. B., Newman, R. A., Wolff, R. A., Kunnumakkara, A. B., Abbruzzese, J. L., Ng, C. S., Badmaev, V. and Kurzrock, R. (2008) Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 14, 4491-4499.